US Bancorp DE Reduces Stock Position in Cognex Corporation $CGNX

US Bancorp DE cut its stake in Cognex Corporation (NASDAQ:CGNX) by 6.3% in the second quarter, HoldingsChannel reports. The institutional investor owned 36,245 shares of the scientific and technical instruments company’s stock after selling 2,448 shares during the quarter. US Bancorp DE’s holdings in Cognex were worth $1,150,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. increased its holdings in Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after buying an additional 736 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in Cognex by 439.4% in the first quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company’s stock valued at $29,000 after buying an additional 791 shares in the last quarter. GAMMA Investing LLC increased its holdings in Cognex by 155.3% in the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company’s stock valued at $32,000 after buying an additional 646 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in shares of Cognex by 231.9% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock worth $34,000 after purchasing an additional 756 shares in the last quarter. Finally, Global X Japan Co. Ltd. purchased a new position in shares of Cognex during the 1st quarter worth approximately $38,000. 88.12% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CGNX has been the subject of a number of recent research reports. Melius raised shares of Cognex from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a research note on Thursday, July 10th. Needham & Company LLC raised their price objective on shares of Cognex from $36.00 to $45.00 and gave the stock a “buy” rating in a research note on Thursday, July 31st. UBS Group raised their price objective on shares of Cognex from $53.00 to $58.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. DA Davidson raised their price objective on shares of Cognex from $32.00 to $35.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Finally, Truist Financial set a $45.00 price objective on shares of Cognex and gave the stock a “hold” rating in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $44.93.

Insider Buying and Selling at Cognex

In other Cognex news, EVP Sheila Marie Dipalma sold 2,002 shares of Cognex stock in a transaction on Friday, September 5th. The shares were sold at an average price of $45.00, for a total value of $90,090.00. Following the transaction, the executive vice president owned 8,582 shares in the company, valued at $386,190. This trade represents a 18.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is currently owned by company insiders.

Cognex Stock Down 0.6%

Shares of CGNX opened at $46.04 on Friday. The firm has a market cap of $7.73 billion, a PE ratio of 64.85 and a beta of 1.50. The company’s fifty day moving average is $44.62 and its two-hundred day moving average is $35.42. Cognex Corporation has a fifty-two week low of $22.67 and a fifty-two week high of $47.52.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. The company had revenue of $249.09 million for the quarter, compared to analyst estimates of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. Cognex’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same quarter last year, the business earned $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. As a group, equities research analysts anticipate that Cognex Corporation will post 0.61 earnings per share for the current year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were issued a $0.08 dividend. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Thursday, August 14th. Cognex’s dividend payout ratio (DPR) is 45.07%.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.